The World Market for Vegetable Alkaloids and Their Salts, Ethers, Esters and Other Derivatives Excluding Medicaments: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for vegetable alkaloids and their salts, ethers, esters and other derivatives excluding medicaments. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for vegetable alkaloids and their salts, ethers, esters and other derivatives excluding medicaments for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
"Vegetable alkaloids and their salts, ethers, esters and other derivatives excluding medicaments" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "vegetable alkaloids and their salts, ethers, esters and other derivatives excluding medicaments" is 5414.
- 1 METHODOLOGY
- 1.1 OUR APPROACH
- 2 THE WORLD MARKET
- 2.1 EXPORTS
- 2.1.1 THE WORLD MARKET: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS EXPORT SUPPLIES IN 2024
- 2.2 IMPORTS
- 2.2.1 THE WORLD MARKET: IMPORTED VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3 EXPORTS
- 3.1 AFRICA: EXPORT SUPPLIES OF VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3.1.1 EXECUTIVE SUMMARY
- 3.1.2 EGYPT
- 3.1.3 GHANA
- 3.1.4 KENYA
- 3.1.5 MADAGASCAR
- 3.1.6 MOROCCO
- 3.1.7 RWANDA
- 3.1.8 SOUTH AFRICA
- 3.1.9 THE DEMOCRATIC REPUBLIC OF THE CONGO
- 3.1.10 THE REPUBLIC OF THE CONGO
- 3.2 ASIA: EXPORT SUPPLIES OF VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3.2.1 EXECUTIVE SUMMARY
- 3.2.2 CHINA
- 3.2.3 HONG KONG
- 3.2.4 INDIA
- 3.2.5 INDONESIA
- 3.2.6 JAPAN
- 3.2.7 MALAYSIA
- 3.2.8 SINGAPORE
- 3.2.9 SOUTH KOREA
- 3.2.10 TAIWAN
- 3.2.11 VIETNAM
- 3.3 EUROPE: EXPORT SUPPLIES OF VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3.3.1 EXECUTIVE SUMMARY
- 3.3.2 AUSTRIA
- 3.3.3 BELGIUM
- 3.3.4 BULGARIA
- 3.3.5 CYPRUS
- 3.3.6 DENMARK
- 3.3.7 FINLAND
- 3.3.8 FRANCE
- 3.3.9 GEORGIA
- 3.3.10 GERMANY
- 3.3.11 GREECE
- 3.3.12 HUNGARY
- 3.3.13 IRELAND
- 3.3.14 ITALY
- 3.3.15 LITHUANIA
- 3.3.16 LUXEMBOURG
- 3.3.17 MALTA
- 3.3.18 NORWAY
- 3.3.19 POLAND
- 3.3.20 PORTUGAL
- 3.3.21 ROMANIA
- 3.3.22 RUSSIA
- 3.3.23 SLOVAKIA
- 3.3.24 SLOVENIA
- 3.3.25 SPAIN
- 3.3.26 SWEDEN
- 3.3.27 SWITZERLAND
- 3.3.28 THE CZECH REPUBLIC
- 3.3.29 THE NETHERLANDS
- 3.3.30 THE UNITED KINGDOM
- 3.3.31 UKRAINE
- 3.4 LATIN AMERICA: EXPORT SUPPLIES OF VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3.4.1 EXECUTIVE SUMMARY
- 3.4.2 ARGENTINA
- 3.4.3 BELIZE
- 3.4.4 BRAZIL
- 3.4.5 COLOMBIA
- 3.4.6 EL SALVADOR
- 3.4.7 MEXICO
- 3.4.8 PERU
- 3.4.9 URUGUAY
- 3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3.5.1 EXECUTIVE SUMMARY
- 3.5.2 CANADA
- 3.5.3 THE UNITED STATES
- 3.6 OCEANIA: EXPORT SUPPLIES OF VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3.6.1 EXECUTIVE SUMMARY
- 3.6.2 AUSTRALIA
- 3.6.3 NEW ZEALAND
- 3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IN 2024
- 3.7.1 EXECUTIVE SUMMARY
- 3.7.2 IRAN
- 3.7.3 ISRAEL
- 3.7.4 THE UNITED ARAB EMIRATES
- 3.7.5 TURKEY
- 3.7.6 UZBEKISTAN
- 4 IMPORTS
- 4.1 AFRICA: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IMPORTS IN 2024
- 4.1.1 EXECUTIVE SUMMARY
- 4.1.2 ALGERIA
- 4.1.3 CAMEROON
- 4.1.4 COTE D'IVOIRE
- 4.1.5 EGYPT
- 4.1.6 ETHIOPIA
- 4.1.7 MADAGASCAR
- 4.1.8 MALAWI
- 4.1.9 MAURITANIA
- 4.1.10 MOROCCO
- 4.1.11 NIGERIA
- 4.1.12 SAO TOME E PRINCIPE
- 4.1.13 SENEGAL
- 4.1.14 SOUTH AFRICA
- 4.1.15 TANZANIA
- 4.1.16 UGANDA
- 4.1.17 ZIMBABWE
- 4.2 ASIA: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IMPORTS IN 2024
- 4.2.1 EXECUTIVE SUMMARY
- 4.2.2 CHINA
- 4.2.3 HONG KONG
- 4.2.4 INDIA
- 4.2.5 INDONESIA
- 4.2.6 JAPAN
- 4.2.7 MALAYSIA
- 4.2.8 NEPAL
- 4.2.9 SINGAPORE
- 4.2.10 SOUTH KOREA
- 4.2.11 SRI LANKA
- 4.2.12 TAIWAN
- 4.2.13 THAILAND
- 4.2.14 THE PHILIPPINES
- 4.2.15 VIETNAM
- 4.3 EUROPE: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IMPORTS IN 2024
- 4.3.1 EXECUTIVE SUMMARY
- 4.3.2 AUSTRIA
- 4.3.3 BELARUS
- 4.3.4 BELGIUM
- 4.3.5 BOSNIA AND HERZEGOVINA
- 4.3.6 BULGARIA
- 4.3.7 CROATIA
- 4.3.8 CYPRUS
- 4.3.9 DENMARK
- 4.3.10 ESTONIA
- 4.3.11 FINLAND
- 4.3.12 FRANCE
- 4.3.13 GEORGIA
- 4.3.14 GERMANY
- 4.3.15 GREECE
- 4.3.16 HUNGARY
- 4.3.17 ICELAND
- 4.3.18 IRELAND
- 4.3.19 ITALY
- 4.3.20 KAZAKHSTAN
- 4.3.21 LITHUANIA
- 4.3.22 LUXEMBOURG
- 4.3.23 MACEDONIA
- 4.3.24 MALTA
- 4.3.25 NORWAY
- 4.3.26 POLAND
- 4.3.27 PORTUGAL
- 4.3.28 ROMANIA
- 4.3.29 RUSSIA
- 4.3.30 SLOVAKIA
- 4.3.31 SLOVENIA
- 4.3.32 SPAIN
- 4.3.33 SWEDEN
- 4.3.34 SWITZERLAND
- 4.3.35 THE CZECH REPUBLIC
- 4.3.36 THE NETHERLANDS
- 4.3.37 THE UNITED KINGDOM
- 4.3.38 UKRAINE
- 4.4 LATIN AMERICA: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IMPORTS IN 2024
- 4.4.1 EXECUTIVE SUMMARY
- 4.4.2 ARGENTINA
- 4.4.3 BOLIVIA
- 4.4.4 BRAZIL
- 4.4.5 CHILE
- 4.4.6 COLOMBIA
- 4.4.7 ECUADOR
- 4.4.8 EL SALVADOR
- 4.4.9 GUATEMALA
- 4.4.10 GUYANA
- 4.4.11 HONDURAS
- 4.4.12 MEXICO
- 4.4.13 PANAMA
- 4.4.14 PARAGUAY
- 4.4.15 PERU
- 4.4.16 URUGUAY
- 4.5 NORTH AMERICA & THE CARIBBEAN: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IMPORTS IN 2024
- 4.5.1 EXECUTIVE SUMMARY
- 4.5.2 BARBADOS
- 4.5.3 CANADA
- 4.5.4 THE DOMINICAN REPUBLIC
- 4.5.5 THE UNITED STATES
- 4.6 OCEANIA: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IMPORTS IN 2024
- 4.6.1 EXECUTIVE SUMMARY
- 4.6.2 AUSTRALIA
- 4.6.3 FIJI
- 4.6.4 NEW ZEALAND
- 4.7 THE MIDDLE EAST: VEGETABLE ALKALOIDS AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES EXCLUDING MEDICAMENTS IMPORTS IN 2024
- 4.7.1 EXECUTIVE SUMMARY
- 4.7.2 ISRAEL
- 4.7.3 JORDAN
- 4.7.4 KUWAIT
- 4.7.5 LEBANON
- 4.7.6 OMAN
- 4.7.7 PAKISTAN
- 4.7.8 TURKEY
- 4.7.9 YEMEN
- 5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
- 5.1 DISCLAIMERS & SAFE HARBOR
- 5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook